Reprint of: Cancer incidence and mortality patterns in South Eastern Europe in the last decade: Gaps persist compared with the rest of Europe |
| |
| Affiliation: | 1. Croatian National Cancer Registry, Croatian National Institute of Public Health, Zagreb, Croatia;2. Comprehensive Cancer Centre South (IKZ), Eindhoven, The Netherlands;3. Slovenian Cancer Registry, Oncology Institute, Lubljana, Slovenia;4. Malta National Cancer Registry, Department of Health Information and Research, Pieta, Malta;5. Regional Cancer Registry of Cluj, Oncological Institute “Ion Chiricuta”, Cluj-Napoca, Romania;6. Cyprus Cancer Registry-Health Monitoring Unit, Ministry of Health, Nicosia, Cyprus;7. Bulgarian National Cancer Registry, National Oncology Hospital, Sofia, Bulgaria;8. Izmir Cancer Registry, Izmir, Turkey;9. Antalya Cancer Registry, Antalya, Turkey;10. Institute of Public Health Serbia, Belgrade, Serbia;11. Section of Cancer Information, International Agency for Research on Cancer, Lyon, France;12. Dept. of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands;1. Eindhoven Cancer Registry & Erasmus University Medical Cancer Centre;2. National Cancer Registry;3. Piedmont Cancer Registry;1. Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France;2. Childhood Cancer Research Group, University of Oxford, Oxford, UK;3. German Childhood Cancer Registry, University Medical Centre, Mainz, Germany;4. Piedmont Cancer Registry, Centre for Cancer Prevention, Torino, Italy;5. Spanish Registry of Childhood Tumours (RETI-SEHOP), University of Valencia, Valencia, Spain;1. Belgian Cancer Registry, Brussels, Belgium;2. Department of Abdominal Surgery, University Clinic Gasthuisberg, Leuven, Belgium;3. Department of Digestive, Endocrine and General Surgery, CHU Mont-Godinne, Yvoir, Belgium;1. Piedmont Cancer Registry, CPO, Via San Francesco da Paola 31, 10123 Turin, Italy;2. Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Division Medical Biometry, University Medical Center of the Johannes Gutenberg, University Mainz, Langenbeckstr. 1, D 55131 Mainz, Germany;3. Registre des Cancers du Bas-Rhin, 11 rue Humann, 67085 Strasbourg Cedex, France;4. Ticino Cancer Registry, Istituto cantonale di patologia, Via Selva 24, 6601 Locarno, Switzerland;5. Cluj Regional Cancer Registry, Dept. of Epidemiology & Medical Biostatistics, Oncological Institute ‘Ion Chiricuta’, Republicii Street No. 34-36, 400015 Cluj Napoca, Romania;6. Ferrara Cancer Registry, Via Fossato di Mortara 64B, 44121 Ferrara, Italy;7. Tarragona Cancer Registry, Foundation Society for Cancer Research and Prevention, IISPV, C/Josep Laporte, 1, 43204 Reus, Spain;8. Northern Ireland Cancer Registry, Dept. of Epidemiology & Public Health, Queen’s University Inst. of Clinical Science, Mulhouse Bldg, Grosvenor Road, BT12 6BJ Belfast, Northern Ireland, UK;9. Basque Cancer Registry, Servicio de Registros e Informacion Sanitaria, Departamento de Salud del Gobierno Vasco, 01010 Donostia-San Sebastian 1, 01010 Vitoria-Gasteiz, Spain;10. Thames Cancer Registry, King’s College London, Cancer Epidemiology and Population Health, 1st Floor, Capital House, 42 Weston Street, SE1 3QD London, UK;11. Icelandic Cancer Registry, Icelandic Cancer Society, P.O. Box 5420, Skógarhlíd 8, 125 Reykjavik, Iceland;12. Belgian Cancer Registry, Koningstraat 215, 1210 Brussels, Belgium;13. Cancer Registry of Republic of Slovenia, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia;14. IKZ Integraal Kankercentrum Zuid, P.O. Box 231, 5600 AE Eindhoven, The Netherlands;1. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Pieni Roobertinkatu 9, FI-00130 Helsinki, Finland;2. Department of Mathematical Sciences, University of Oulu, Oulu, Finland;2. Dept. of Public Health, Erasmus University Medical Cancer Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands;3. Dept. of Registration and Research, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501 DB Utrecht, The Netherlands;4. Piedmont Cancer Registry – CPO, Centre for Cancer Prevention, Torino, Italy;5. National Cancer Registry, Building 6800, Cork Airport Business Park, Cork, Ireland;6. Dept. of Cancer Information, Danish Cancer Society (DCS), Copenhagen, Denmark;7. Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy;8. Dept. of Clinical Epidemiology, Viecuri Medical Centre, PO Box 1926, 5900 BX Venlo, The Netherlands;9. Dept. of Clinical Psychology, Tilburg University, PO Box 90153, 5000 LB Tilburg, The Netherlands;10. Dept. of Health Technology and Services Research, MIRA Institute of Biomedical Science and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands |
| |
| Abstract: | IntroductionCancer registration coverage and cancer control programmes in South Eastern (SE) Europe, embracing about six new EU member states, remain thin, despite a relatively high incidence and mortality burden from avoidable cancers, particularly in males. We assembled the most recent cancer registry data to estimate the burden of the 17 most common cancers in the region, from Slovenia to Cyprus and Malta.MethodsData were made available for analysis from Bulgaria, Croatia, Cyprus, Malta, Romania (Cluj County), Serbia, Slovenia and Turkey (Antalya and Izmir provinces). We analysed incidence and mortality of the 17 most common cancers (counts and age-standardised rates, for the most recent year available and for the period 1999–2008). We used Joinpoint regression to quantify recent trends.FindingsFor much of SE Europe, there were no marked declines in overall cancer mortality rates during 1999–2008. In men, lung cancer incidence and mortality rates were high compared to other European countries (age-standardised rates (ASRW) of incidence being 50–60/100,000 in most of the countries), and are still increasing in Bulgaria, Serbia and Turkey. Prostate cancer incidence rapidly increased throughout the region by 3–12% annually, largely without any clear declines in mortality. Colorectal cancer incidence increased throughout the region, as did mortality especially in Croatia, Serbia and Bulgaria (average annual percentage change (AAPC) 1.5–2%). In women, breast cancer mortality significantly declined in Slovenia, Croatia and Malta (AAPC −2%, −1% and −5%, respectively), but not elsewhere. Cervical cancer incidence rates remained very high in Romania, Serbia and Bulgaria (ASRW >20/100,000).InterpretationOur data confirmed the North West to South East Europe gradient of increasing incidence and mortality rates of tobacco-related cancers, as well as increasing mortality rates of screen-detectable cancers. Lack of decline in overall cancer mortality also indicates suboptimal levels of cancer control in the region. |
| |
| Keywords: | Epidemiology Cancer Incidence Mortality |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
